Clinical Trial Update: Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating lenalidomide with vorinostat, gemcitabine, busulfan, and melphalan with autologous stem-cell transplantation in diffuse large B-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Lymphoma

Drugs mentioned

• Autologous stem cell transplantation (autologous stem cell transplantation)
• BUSULFAN (Busulfan)
• Gemcitabine (Gemcitabine)
• Lenalidomide (lenalidomide)
• Melphalan (Melphalan)
• Vorinostat (vorinostat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-12-13